Demographic and clinical parameters in 40 inpatients suffering from unipolar depression treated with either reboxetine (n = 20; 8 mg/day) or mirtazapine (n = 20; 45 mg/day) for 5 weeks (sample 1) [33].

Mean±standard deviation (SD) is indicated. Patients are subdivided into COR week 1 Im (improvers)/COR peak NIm (nonimprovers) and into COR week 5 Im/NIm. COR peak week 1/week 5 Im ( = COR peak week 1/week 5 improver): patient with reduction of COR peak value in the DEX/CRH test after 1 week/5 weeks of treatment, as compared to baseline (week 0). MD = Major Depression. M = male, F = female. BMI = body mass index. 21-HAMD = Hamilton Depression Rating Scale, 21-item version. Statistics: results of χ2-test or oneway ANOVA are provided.